Posters provide background information and trial designs for ongoing clinical studies of wholly-owned NX-2127 and…
Data from an eight-patient, open-label study demonstrate improvements across multiple biomarkers of mitochondrial function, inflammation,…
All patients treated with bezuclastinib achieved ≥50% reduction in serum tryptase, with a median reduction…
CHESTERBROOK, Pa., June 10, 2022 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company…
— NDA filing for Nirogacestat in Desmoid Tumors, Which Will Be Reviewed Under the FDA’s…
Internet City, Dubai–(Newsfile Corp. – June 10, 2022) – LBank Exchange, a global digital asset…
Toronto, Ontario–(Newsfile Corp. – June 10, 2022) – Tenet Fintech Group Inc. (CSE: PKK) (OTC…
Internet, Everywhere–(Newsfile Corp. – June 10, 2022) – Shopify Inc. (NYSE, TSX: SHOP), a provider…
KUALA LUMPUR, Jun 10, 2022 – (ACN Newswire) – Hektar Asset Management Sdn. Bhd., the…
CYPRESS, Calif.–(BUSINESS WIRE)–Yamaha Motor Manufacturing Corporation (YMMC), based in Newnan, Georgia, broke ground yesterday on…
Beachwaver’s new summer floral headband is available for virtual try-on in the YouCam Makeup App…
SAN JOSE, Calif.–(BUSINESS WIRE)–YuJa, Inc., a leader in enterprise ed-tech solutions, released a number of…
LONDON, UK – Jun 10th, 2022 – MYCOM OSI, a leading independent provider of Assurance,…
Keros Therapeutics will be hosting a conference call and webcast today, June 10, 2022, at…
UK’s NICE issued its draft Final Appraisal Document (FAD) recommending the use of VAZKEPA® (icosapent…
BARDA has ordered 500,000 doses of liquid-frozen JYNNEOS® to be manufactured from existing bulk vaccine…
Posters include preclinical data on SYK inhibition in combination with targeted agents suggesting evidence of…
SHANGHAI, Jun 10, 2022 – (ACN Newswire) – Brazilian Trade and Investment Promotion Agency (“ApexBrasil”)…
LONDON–(BUSINESS WIRE)–#CapitalStructure–H.I.G. Bayside Capital (“Bayside”), the special situations and distressed debt affiliate of H.I.G. Capital…
WALTHAM, Mass. and STOCKHOLM, Sweden, June 10, 2022 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq:…